Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;35(1):236-243.
doi: 10.1038/s41433-020-01263-6. Epub 2020 Nov 9.

Optical coherence tomography in the 2020s-outside the eye clinic

Affiliations
Review

Optical coherence tomography in the 2020s-outside the eye clinic

Reena Chopra et al. Eye (Lond). 2021 Jan.

Abstract

Optical coherence tomography (OCT) is a paragon of success in the translation of biophotonics science to clinical practice. OCT systems have become ubiquitous in eye clinics but access beyond this is limited by their cost, size and the skill required to operate the devices. Remarkable progress has been made in the development of OCT technology to improve the speed of acquisition, the quality of images and into functional extensions of OCT such as OCT angiography. However, more needs to be done to radically improve the access to OCT by addressing its limitations and enable penetration outside of typical clinical settings and into underserved populations. Beyond high-income countries, there are 6.5 billion people with similar eye-care needs, which cannot be met by the current generation of bulky, expensive and complex OCT systems. In addition, advancing the portability of this technology to address opportunities in point-of-care diagnostics, telemedicine and remote monitoring may aid development of personalised medicine. In this review, we discuss the major milestones in OCT hardware development to reach those beyond the eye clinic.

摘要: 相干光断层扫描成像技术 (Optical coherence tomography, OCT) 是将生物光子学在临床实践中应用的成功典范 。在眼科门诊中, OCT 系统得到了广泛应用, 但是由于其成本高、体积大以及需要具备操作技能的原因, OCT 系统在门诊之外的应用受到限制。目前, OCT 技术的发展在提高图像获取速度、图片质量以及OCT在血管功能检测的拓展应用 (如OCT血管成像技术) 方面取得了显著进展。然而, 我们还需通过解决OCT技术的局限性问题以从根本上改善OCT的应用范围方面做更多的工作, 将OCT技术在典型的临床环境之外以及医学资源相对匮乏的地区人群中得以应用。在高收入国家之外, 还有65亿人有类似的眼保健需求, 而目前这一代OCT系统因其庞大、昂贵和复杂而无法满足这些需求。此外, 提高OCT设备的便携性可为医疗点诊断、远程医疗以及远程监护提供可能, 这有助于个体化医疗的发展。在这篇综述中, 我们主要讨论了OCT硬件发展中为实现OCT技术在眼科门诊之外应用目标的里程碑式的成绩。.

PubMed Disclaimer

Conflict of interest statement

PAK has acted as a consultant for DeepMind, Roche, Novartis and Apellis and is an equity owner in Big Picture Medical. He has received speaker fees from Heidelberg Engineering, Topcon, Allergan and Bayer. RC is an employee of Google LLC and owns Alphabet stock.

Figures

Fig. 1
Fig. 1. Heidelberg Engineering Spectralis Flex Module in use.
The system is affixed to a moveable stand with a flexible arm. Images courtesy of Dr Xiaoxuan Liu and Dr Aditya Kale, University Hospitals Birmingham NHS Foundation Trust.
Fig. 2
Fig. 2. Representative images from patients with pathology that were acquired by the low-cost OCT (LC) and the Heidelberg Engineering Spectralis (HE) systems.
Scale bars: 500 μm. Images courtesy of Prof. Adam Wax, Duke University.
Fig. 3
Fig. 3. Low-cost, handhled OCT system developed by Duke University.
A Complete low-cost OCT system showing PC, touchscreen and scanner. B Detailed composition inside the low-cost OCT handheld scanner. Images courtesy of Prof. Adam Wax, Duke University.
Fig. 4
Fig. 4. Pupillometry in a patient with a right relative afferent pupillary defect (RAPD), using the binocular optical coherence tomography system.
A Resting diameters pre-stimulus; B flash presented to the left eye, constriction of both pupils observed; C both pupils dilated to their resting diameter; D flash presented to the right eye. Constriction amplitude of both eyes is less than that observed when the flash was presented to the left eye.
Fig. 5
Fig. 5. Proposed Home OCT, Notal Vision.
Images courtesy of Prof. Anat Loewenstein,Tel Aviv University.
Fig. 6
Fig. 6. Home-based MIMO-OCT system.
Images courtesy of Dr Peter Maloca, University of Basel.

References

    1. Rosenfeld PJ. Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2016;57:OCT14–26. doi: 10.1167/iovs.16-19969. - DOI - PMC - PubMed
    1. Olson J, Sharp P, Goatman K, Prescott G, Scotland G, Fleming A, et al. Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol Assess. 2013;17:1–142.. doi: 10.3310/hta17510. - DOI - PMC - PubMed
    1. Food and Drug Administration. 510(k) Premarket notification, Envisu Spectral Domain Ophthalmic Imaging System (SDOIS). 2012. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K120057. Accessed 23 Aug 2020.
    1. Maloney R. The Optovue iVue OCT System from Grafton Optical: the possibilities of hand-held OCT devices in ophthalmic practice. J Vis Commun Med. 2012;35:76–81. doi: 10.3109/17453054.2012.690130. - DOI - PubMed
    1. Liu X, Kale AU, Capewell N, Talbot N, Ahmed S, Keane PA, et al. Optical coherence tomography (OCT) in unconscious and systemically unwell patients using a mobile OCT device: a pilot study. BMJ Open. 2019;9:e030882. doi: 10.1136/bmjopen-2019-030882. - DOI - PMC - PubMed

Publication types